3Sbio Overview

  • Founded
  • 1993
Founded
  • Status
  • Public
  • Employees
  • 5,584
Employees
  • Stock Symbol
  • 01530
Stock Symbol
  • Investments
  • 14
  • Share Price
  • $1.34
  • (As of Thursday Closing)

3Sbio General Information

Description

3SBio Inc, or 3SBio, is one of the largest and most established biotech drugmakers in China. In 2020, it reported revenue of CNY 5.6 billion. Approximately 75% of its revenue is derived from three core drugs: TPIAO (rhTPO), Yisaipu (biosimilar of etanercept, a TNF-alpha inhibitor), and EPIAO (rhEPO), which are all older generation biologics. The company has a pipeline of 32 products, of which 22 are biologics and 10 are small molecules, but most of the candidates are still early-stage.

Contact Information

Website
www.3sbio.com
Ownership Status
Publicly Held
Financing Status
Formerly PE-Backed
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Biotechnology
Stock Exchange
HKG
Primary Office
  • 1st 3, 10th Road
  • Economic and Technological Development Zone
  • Shenyang, Liaoning
  • China
+86 024 0000 0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

3Sbio Stock Performance

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$1.34 $1.28 $0.87 - $1.87 $3.41B 2.54B 14M $0.05

3Sbio Financials Summary

In Thousands,
USD
TTM 31-Dec-2020 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 2,418,550 2,418,550 3,560,269 3,478,282
Revenue 808,793 808,793 769,663 692,921
EBITDA 193,668 193,668 232,014 285,833
Net Income 120,978 120,978 140,922 193,063
Total Assets 2,705,860 2,705,860 2,116,583 2,011,870
Total Debt 446,041 446,041 401,816 478,946
Public Fundamental Data provided by Morningstar, Inc. disclaimer

3Sbio Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore 3Sbio‘s full profile, request access.

Request a free trial

3Sbio Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
3SBio Inc, or 3SBio, is one of the largest and most established biotech drugmakers in China. In 2020, it reported revenu
Pharmaceuticals
Shenyang, China
5,584 As of 2020
00000
00000000 00000

00000000

cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in cul
0000 000000000
Suzhou, China
0000 As of 0000
00.000
000000000 00.000

0000 000

t esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt
000000000000000
Petach Tikva, Israel
00000 As of 0000
00000
00000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

3Sbio Competitors (3)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Innovent Biologics Formerly PE-Backed Suzhou, China 0000 00.000 000000000 00.000
0000 0000000000000 Corporate Backed or Acquired Petach Tikva, Israel 00000 00000 00000000000 00000
000000000 Formerly VC-backed South San Francisco, CA 00000 000.00 00000000000
You’re viewing 3 of 3 competitors. Get the full list »

3Sbio Executive Team (6)

Name Title Board Seat Contact Info
Jing Lou Ph.D Chairman, Chief Executive Officer, President and Executive Director
Bo Tan Chief Financial Officer, Executive Vice President and Executive Director
Weihong Xiao Chief Operating Officer
Lu Xia Director, Investor Relations
Thomas Folinsbee Division Director, Corporate Development of Strategic Investment
You’re viewing 5 of 6 executive team members. Get the full list »

3Sbio Board Members (1)

Name Representing Role Since
0000 000 00.0 3Sbio Chairman, Chief Executive Officer, President and Executive Director 000 0000
To view 3Sbio’s complete board members history, request access »

3Sbio Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

3Sbio Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore 3Sbio‘s full profile, request access.

Request a free trial

3Sbio Investments & Acquisitions (14)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 0000000000 21-Oct-2019 00000 00000 00 0000 Drug Discovery 00000000 000 00.0
0000000 0000000000 12-Feb-2019 000000000 0000 Drug Discovery 00000000 000 00.0
000000 0000000 02-May-2018 00000 00000 00 0000 Biotechnology 0000 000 00.0
000000 000000000 01-Dec-2017 00 000000000000000 000.00 Biotechnology 0000 000 00.0
Therapure Biopharma (Contract Development & Manufacturing Assets) 03-Sep-2017 Merger/Acquisition 00000 Biotechnology 0000 000 00.0
You’re viewing 5 of 14 investments and acquisitions. Get the full list »

3Sbio Subsidiaries (1)

Company Name Industry Location Founded
000000 00000000000 Drug Delivery Villa Guardia, Italy 0000
To view 3Sbio’s complete subsidiaries history, request access »

3Sbio Exits (2)

Company Name Exit Date Exit Type Exit Size Status Buyers
000000000 00000000 03-Sep-2017 000000000000000000 00000 Completed
  • 2 buyers
Ascentage Pharma 11-Feb-2010 Corporate 000 Completed
To view 3Sbio’s complete exits history, request access »